Fake Ozempic pens found in Australia
The Therapeutic Goods Administration (TGA) has urged the diabetes community to stay alert after counterfeit Ozempic-labelled injection pens have been stopped at the Australian border.
These fake medicines have not been assessed for quality, safety, or effectiveness and should not be used under any circumstances.
The counterfeit pens closely resemble genuine Ozempic 1mg products, however they are falsely labelled with the batch number MPSD916.
Novo Nordisk, the manufacturer of Ozempic, has confirmed this is not a genuine batch number.
What to look out for
- Products marked with batch number
- Differences in the spacing and bolding of the text on the packaging, compared to legitimate Ozempic products.
- Products purchased over the internet may be fake.
- For your safety, always purchase medicines from reputable sources and chat to your pharmacy or healthcare provider if you have concerns.
Counterfeit medicines can be dangerous
Use extreme caution when buying medicines from unknown overseas websites. Diabetes Victoria recommends only buying diabetes products from an Australian pharmacy.
Counterfeit products may contain incorrect or harmful ingredients and they cannot be imported under the Personal Importation Scheme.
I’m not sure about my product
If your product is marked with batch number MPSD916 do not use it. Take it to your local pharmacy for safe disposal.
If you have any concerns about your diabetes products, talk to your doctor or diabetes educator.
For more information, visit the TGA website.
Britt Denton
Communications and Media Lead
Brittany Denton is the Communications and Media Lead at Diabetes Victoria. She oversees media relations and communications, contributing to the organisation’s mission of supporting people with diabetes across the state.
